Town Hall: Level the Playing Field for Drug Companies and Patients

According to the Centers for Medicare and Medicaid Services (CMS), prescription drug expenditure in the United States amounted to a total of $358.7 billion in 2020. It’s estimated that Americans pay around $1,200 each year for prescription medication, well above other comparable countries. One significant cause of high drug prices are the Pharmacy Benefit Managers (PBMs). To read this […]

AI Offers Substantial Benefits for Patients

On April 21, the European Commission released its much-anticipated proposal for a regulation laying down harmonized rules on artificial intelligence. If implemented, Brussels’ proposal would govern artificial intelligence (AI) across 27 member countries and for over 445 million people. In outlining the need for the Commission’s proposed AI regulations, Margrethe Vestager, Executive Vice-President for a Europe fit for […]

New Medicare Program Will Lead to More Costs Than Benefits for Some Homebound Patients

The Centers for Medicare & Medicaid Services (CMS) is implementing a bidding program that it hopes will lead to lower-priced devices and drive down Medicare costs for the homecare patients.  However, auction bidding experts have overwhelmingly found that the current program will lead to below-cost pricing, which would adversely affect supply.  The resulting decrease in […]